Related references
Note: Only part of the references are listed.Macronutrients during Pregnancy and Life-Threatening Respiratory Syncytial Virus Infections in Children
F. Martin Ferolla et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Adults 65 Years Old and Older Have Reduced Numbers of Functional Memory T Cells to Respiratory Syncytial Virus Fusion Protein
Anu Cherukuri et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections
N. Lee et al.
CLINICAL INFECTIOUS DISEASES (2013)
Attenuation of Live Respiratory Syncytial Virus Vaccines Is Associated With Reductions in Levels of Nasal Cytokines
Ruth A. Karron et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Kinetics of the Neutralizing Antibody Response to Respiratory Syncytial Virus Infections in a Birth Cohort
C. J. Sande et al.
JOURNAL OF MEDICAL VIROLOGY (2013)
Regulatory T Cells Prevent Th2 Immune Responses and Pulmonary Eosinophilia during Respiratory Syncytial Virus Infection in Mice
Lydia R. Durant et al.
JOURNAL OF VIROLOGY (2013)
Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses
Tatiana Chirkova et al.
JOURNAL OF VIROLOGY (2013)
A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice
Seyhan Boyoglu-Barnum et al.
JOURNAL OF VIROLOGY (2013)
Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants
Maarten O. Blanken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age
Caroline Breese et al.
PEDIATRICS (2013)
Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age
Elissa Malkin et al.
PLOS ONE (2013)
Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection
John S. Tregoning et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells
Jens Loebbermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
Jason S. McLellan et al.
SCIENCE (2013)
Respiratory syncytial virus vaccine development
Larry J. Anderson
SEMINARS IN IMMUNOLOGY (2013)
Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells
Christine L. Nelson et al.
VACCINE (2013)
The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease
Christine A. Shaw et al.
VACCINE (2013)
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine
Gregory M. Glenn et al.
VACCINE (2013)
Bovine respiratory syncytial virus: infection dynamics within and between herds
T. B. Klem et al.
VETERINARY RECORD (2013)
Respiratory Syncytial Virus: Current Progress in Vaccine Development
Rajeev Rudraraju et al.
VIRUSES-BASEL (2013)
Protective and dysregulated T cell immunity in RSV infection
Peter J. Openshaw et al.
CURRENT OPINION IN VIROLOGY (2013)
Advances in and the potential of vaccines for respiratory syncytial virus
Patricia A. Jorquera et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2013)
Increased Genetic and Phenotypic Stability of a Promising Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate by Reverse Genetics
Cindy Luongo et al.
JOURNAL OF VIROLOGY (2012)
Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
Gale Smith et al.
PLOS ONE (2012)
Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children
David I. Bernstein et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures
Jeanne H. Schickli et al.
VIRUS RESEARCH (2012)
A Critical Phenylalanine Residue in the Respiratory Syncytial Virus Fusion Protein Cytoplasmic Tail Mediates Assembly of Internal Viral Proteins into Viral Filaments and Particles
Fyza Y. Shaikh et al.
MBIO (2012)
Animal models of human respiratory syncytial virus disease
Reinout A. Bem et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children
Harish Nair et al.
BMC PUBLIC HEALTH (2011)
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
Barney S. Graham
IMMUNOLOGICAL REVIEWS (2011)
Respiratory Syncytial Virus Binds and Undergoes Transcription in Neutrophils From the Blood and Airways of Infants With Severe Bronchiolitis
Clare P. Halfhide et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
Jason S. McLellan et al.
JOURNAL OF VIROLOGY (2011)
Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
Peter L. Collins et al.
VIRUS RESEARCH (2011)
Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis
Lisa Hartling et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus
John P. DeVincenzo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence
Adriaan F. G. Antonis et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Respiratory Syncytial Virus F and G Proteins Induce Interleukin 1α, CC, and CXC Chemokine Responses by Normal Human Bronchoepithelial Cells
Christine M. Oshansky et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Activation of Interferon Response Through Toll-Like Receptor 3 Impacts Viral Pathogenesis and Pulmonary Toll-Like Receptor Expression During Respiratory Syncytial Virus and Influenza Infections in the Cotton Rat Sigmodon hispidus Model
Marina S. Boukhvalova et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
Neutralization of Human Respiratory Syncytial Virus Infectivity by Antibodies and Low-Molecular-Weight Compounds Targeted against the Fusion Glycoprotein
Margarita Magro et al.
JOURNAL OF VIROLOGY (2010)
Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life
Nele Sigurs et al.
THORAX (2010)
The cotton rat model of respiratory viral infections
Marina S. Boukhvalova et al.
BIOLOGICALS (2009)
Innate Cells and T Helper 2 Cell Immunity in Airway Inflammation
Nora A. Barrett et al.
IMMUNITY (2009)
Human Respiratory Syncytial Virus Nonstructural Protein NS2 Antagonizes the Activation of Beta Interferon Transcription by Interacting with RIG-I
Zhenhua Ling et al.
JOURNAL OF VIROLOGY (2009)
The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya
Rachel Ochola et al.
PLOS ONE (2009)
A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age
Joanne M. Langley et al.
VACCINE (2009)
Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design
Juliana Bessa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction
Masashi Shingai et al.
INTERNATIONAL IMMUNOLOGY (2008)
Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus
Joshua J. Shinoff et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2008)
The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice
John S. Tregoning et al.
JOURNAL OF VIROLOGY (2008)
Effectiveness of maternal influenza immunization in mothers and infants
K. Zaman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Activation of the granzyme pathway in children with severe respiratory syncytial virus infection
Reinout A. Bem et al.
PEDIATRIC RESEARCH (2008)
CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections
Jojanneke Heidema et al.
JOURNAL OF IMMUNOLOGY (2007)
CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease
Matthew R. Olson et al.
JOURNAL OF IMMUNOLOGY (2007)
Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children
Agnes A. Awomoyi et al.
JOURNAL OF IMMUNOLOGY (2007)
TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide
Meri K. Tulic et al.
JOURNAL OF IMMUNOLOGY (2007)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
A potential molecular mechanism for hypersensitivity caused by formalin- inactivated vaccines
Amin Moghaddam et al.
NATURE MEDICINE (2006)
Immune responses and disease enhancement during respiratory syncytial virus infection
PJM Openshaw et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness
MS Lo et al.
JOURNAL OF VIROLOGY (2005)
Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis
PS McNamara et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants
RA Karron et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Role of serum neutralizing antibody in reinfection of respiratory syncytial virus
Y Kawasaki et al.
PEDIATRICS INTERNATIONAL (2004)
Human respiratory syncytial virus matrix protein is an RNA-binding protein:: binding properties, location and identity of the RNA contact residues
L Rodríguez et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Thermostability of the human respiratory syncytial virus fusion protein before and after activation:: implications for the membrane-fusion mechanism
MB Ruiz-Argüello et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Adenoviruses as vaccine vectors
N Tatsis et al.
MOLECULAR THERAPY (2004)
Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice
HS Jafri et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: Exploring the parameters of pathogenesis
AFG Antonis et al.
JOURNAL OF VIROLOGY (2003)
Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis
PS McNamara et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women
FM Munoz et al.
VACCINE (2003)
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
PA Piedra et al.
VACCINE (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses
R Singleton et al.
JOURNAL OF VIROLOGY (2003)
Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus
LM Haynes et al.
JOURNAL OF VIROLOGY (2001)
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
PF Wright et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults
IM Gonzalez et al.
VACCINE (2000)
Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis
A Cade et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2000)
Share Paper
